World's Best Scientists 2026 revealed!
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 151 1106 1017 40 39 1719 96630

Jos H. Beijnen publications per year

The chart shows the history of publications by Jos H. Beijnen between 1980 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jos H. Beijnen published across 46 years, from 1980 to 2025, averaging 40.9 papers a year. Output peaked at 106 publications in 2023. 64 of the 1,882 publications appeared in the last two years.

No. of publications
25 50 75 100
Bar chart. Horizontal axis: year, 1980 to 2025. Vertical axis: number of publications, 0 to 106. Peak 106 publications in 2023. 1980: 3 publications 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 1 publication 1985: 5 publications 1986: 7 publications 1987: 2 publications 1988: 12 publications 1989: 9 publications 1990: 10 publications 1991: 20 publications 1992: 14 publications 1993: 40 publications 1994: 37 publications 1995: 39 publications 1996: 31 publications 1997: 48 publications 1998: 45 publications 1999: 45 publications 2000: 46 publications 2001: 58 publications 2002: 64 publications 2003: 42 publications 2004: 60 publications 2005: 73 publications 2006: 78 publications 2007: 53 publications 2008: 56 publications 2009: 80 publications 2010: 75 publications 2011: 69 publications 2012: 69 publications 2013: 72 publications 2014: 57 publications 2015: 45 publications 2016: 51 publications 2017: 45 publications 2018: 46 publications 2019: 46 publications 2020: 62 publications 2021: 61 publications 2022: 36 publications 2023: 106 publications 2024: 54 publications 2025: 10 publications
1980 2025

1,882 publications in total across all disciplines

View publications per year as a table
Jos H. Beijnen: publications per year, 1980 to 2025
Year Publications
1980 3
1981 0
1982 0
1983 0
1984 1
1985 5
1986 7
1987 2
1988 12
1989 9
1990 10
1991 20
1992 14
1993 40
1994 37
1995 39
1996 31
1997 48
1998 45
1999 45
2000 46
2001 58
2002 64
2003 42
2004 60
2005 73
2006 78
2007 53
2008 56
2009 80
2010 75
2011 69
2012 69
2013 72
2014 57
2015 45
2016 51
2017 45
2018 46
2019 46
2020 62
2021 61
2022 36
2023 106
2024 54
2025 10
Total 1,882
Download as CSV

Jos H. Beijnen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jos H. Beijnen sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,701–1,720 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,719 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10 1,719
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Jos H. Beijnen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jos H. Beijnen sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 150–151 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 151 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79 151
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 2023 - Research.com Medicine in Netherlands Leader Award
  • 2010 - Royal Netherlands Academy of Arts and Sciences

Overview

Jos H. Beijnen is affiliated with Utrecht University in the Netherlands and has a significant body of research primarily in the field of Medicine, with a focus on Oncology, Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine, and Epidemiology.

Their work encompasses various topics, including:

  • Drug Transport and Resistance Mechanisms
  • Pharmacogenetics and Drug Metabolism
  • Colorectal Cancer Treatments and Studies
  • Cancer Treatment and Pharmacology
  • Lung Cancer Treatments and Mutations
  • Cancer therapeutics and mechanisms
  • Pharmacological Effects and Toxicity Studies

Frequent publication venues for Jos H. Beijnen include:

  • Journal of Chromatography B
  • Journal of Pharmaceutical and Biomedical Analysis
  • Clinical Pharmacokinetics
  • Cancer Chemotherapy and Pharmacology
  • Clinical Pharmacology & Therapeutics

Their recent published papers illustrate a strong focus on cancer-related pharmacology and immunotherapy:

  • "Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma," 2022, New England Journal of Medicine
  • "Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up," 2020, Journal for ImmunoTherapy of Cancer
  • "The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?", 2022, International Journal of Molecular Sciences
  • "Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology," 2022, Clinical Pharmacokinetics
  • "Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib," 2020, Clinical Pharmacokinetics

Jos H. Beijnen has worked alongside frequent co-authors such as:

  • Alwin D. R. Huitema
  • Hilde Rosing
  • Alfred H. Schinkel
  • Thomas P. C. Dorlo
  • Neeltje Steeghs

In recognition of scientific contributions, Jos H. Beijnen was awarded membership in the Royal Netherlands Academy of Arts and Sciences in 2010.

Best Publications

  • Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

    A.H. Schinkel;J.J.M. Smit;O. van Tellingen;J.H. Beijnen

  • A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

    Jeany M. Rademaker-Lakhai;Desiree van den Bongard;Dick Pluim;Jos H. Beijnen

  • Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

    A. Sparreboom;J. van Asperen;U. Mayer;A.H. Schinkel

  • The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria

    Johan W. Jonker;Marije Buitelaar;Els Wagenaar;Martin A. van der Valk

  • Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan

    Johan W. Jonker;Johan W. Smit;Remco F. Brinkhuis;Marc Maliepaard

  • Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

    Thomas P. C. Dorlo;Thomas P. C. Dorlo;Manica Balasegaram;Jos H. Beijnen;Peter J. de Vries

  • Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?

    Ellen Stokvis;Hilde Rosing;Jos H. Beijnen;Jos H. Beijnen

  • A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

    Giuseppe Giaccone;Cornelis J. A. Punt;Yoshitaka Ando;Rita Ruijter

  • An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.

    Esther F.A Brandon;Christiaan D Raap;Irma Meijerman;Jos H Beijnen;Jos H Beijnen

  • Clinical pharmacokinetics of therapeutic monoclonal antibodies.

    Ron J. Keizer;Alwin D. R. Huitema;Jan H. M. Schellens;Jan H. M. Schellens;Jos H. Beijnen;Jos H. Beijnen

  • Approaching tumour therapy beyond platinum drugs : status of the art and perspectives of ruthenium drug candidates.

    A. Bergamo;C. Gaiddon;J.H.M. Schellens;J.H. Beijnen

  • Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein

    G J Zaman;J Lankelma;O van Tellingen;J Beijnen

  • Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs

    J Wijnholds;C A Mol;L van Deemter;M de Haas

  • Clinical Pharmacokinetics of Cyclophosphamide

    Milly E de Jonge;Alwin D R Huitema;Sjoerd Rodenhuis;Jos H Beijnen

  • Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein.

    J. Wijnholds;R. Evers;M. R. Van Leusden;C. A. A. M. Mol

  • Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

    Suzanne Leijen;Sjaak A. Burgers;Paul Baas;Dick Pluim

  • Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs.

    Pauline Breedveld;Jos H. Beijnen;Jos H. Beijnen;Jan H.M. Schellens;Jan H.M. Schellens

  • Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients

    M.T. Huizing;A.C.F. Keung;H. Rosing;V. van der Kuij

  • Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors

    K.M. Heinhuis;W. Ros;M. Kok;N. Steeghs

  • Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

    Ulrich Mayer;Els Wagenaar;Birgit Dorobek;Jos H. Beijnen

Frequent Co-Authors

Jan H.M. Schellens
Jan H.M. Schellens Utrecht University
Hilde Rosing
Hilde Rosing Antoni van Leeuwenhoek Hospital
Alfred H. Schinkel
Alfred H. Schinkel Antoni van Leeuwenhoek Hospital
Sjoerd Rodenhuis
Sjoerd Rodenhuis Antoni van Leeuwenhoek Hospital
David M. Burger
David M. Burger Radboud University
Emile E. Voest
Emile E. Voest Antoni van Leeuwenhoek Hospital
John B. A. G. Haanen
John B. A. G. Haanen Antoni van Leeuwenhoek Hospital
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Piet Borst
Piet Borst Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, there are several alternative online degrees and pathways that can help you enter the healthcare field. Many students opt for nursing, especially with flexible absn programs that don't require teas, making it easier to start your nursing education without additional testing barriers.

For those interested in healthcare leadership roles, accelerated healthcare programs offer a fast track to earning a degree in healthcare administration online. These programs are ideal for students wanting to move quickly into management positions within the healthcare sector.

Registered nurses seeking career advancement may consider rn to np bridge programs. These bridge programs provide a smooth transition from an associate degree in nursing to a nurse practitioner role, opening doors to greater responsibility and higher pay.

If you’re passionate about wellness and nutrition, a best online nutrition degree can help you prepare for careers in dietary planning, public health, and nutritional counseling. Online learning has made it easier than ever to pursue these rewarding pathways alongside your existing commitments.

Best Scientists Citing Jos H. Beijnen

Trending Scientists

Recently Published Articles